News ID: 278861
Published: 0257 GMT December 30, 2020

Coronavirus claims 149 more lives in Iran

Coronavirus claims 149 more lives in Iran
IRNA

Iran’s Health Ministry’s spokeswoman Sima Sadat Lari said the death toll from the coronavirus reached 55,095 on Wednesday after the virus took the lives of 149 patients during a 48-hour period.

She also said that the ministry registered 6,272 new positive cases from Tuesday to Wednesday, bringing the total number of new positive cases to 1,218,753, according to IRNA.

Of the new cases, 807 people have been hospitalized across the country, Lari said.

At least 978,714 patients have recovered from the coronavirus infection so far or have been discharged from hospitals across Iran, the spokeswoman added.

The ministry’s official noted that some 5,087 patients are in critical condition and being treated in intensive care units.

Despite the increase in the figures in the past days, Iran has managed to decrease the number of new coronavirus cases and deaths in recent weeks following the government’s imposition of tough restrictions in the country since November 21.

Iran has also extended a nighttime traffic curfew to 330 lower-risk cities and towns in an effort to sustain a recent decline in the number of new coronavirus infections and deaths.

On Tuesday, Iran began the first phase in the human trial of the homegrown COVID-19 vaccine after successfully completing the initial steps, including tests on animals, and obtaining necessary approvals.

The vaccine, produced by Iranian experts at the Headquarters for Executing the Order of Imam Khomeini, was administered to three volunteers at a ceremony in Tehran.

It is dubbed Coviran Barekat after the pharmaceutical group that developed the vaccine against the coronavirus pandemic.

Speaking on the sidelines of the ceremony to launch the vaccine trial, Health Minister Saeid Namaki said, “Today is one of the most promising days for the Iranian nation.”

“It is a day when we could fortunately make the first injection on humans following a long period of efforts on the part of the country’s leading scientists in the field of technology and biotech, who produced the COVID-19 vaccine after various stages, including animal studies and models,” he added.

A total of 56 volunteers would receive two shots administered 14 days apart in the first human trial of the Iranian vaccine and the results will be announced 28 days later.

The vaccine is of the inactivated type, which is made of a virus that is weakened or killed by chemicals.

Iran has also been trying to import the vaccine from other countries. However, the illegal US sanctions has so far hampered Iran’s efforts to import the vaccines.

 

 

   
KeyWords
 
Comments
Comment
Name:
Email:
Comment:
Security Key:
Captcha refresh
Page Generated in 0/1675 sec